Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
11β-HSD1-IN-9
Cat. No.:
OB0425LY-316
Appearance:
Solid
Purity:
≥95%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
11β-HSD1-IN-9 is a compound that selectively inhibits 11β-hydroxysteroid dehydrogenase 1 (11β-HSD1). This enzyme is responsible for converting cortisol to its inactive form in the adrenal cortex and can be used to regulate glucocorticoid activity in the body.
Synonyms:
88283-34-5; 2-Pyrazin-2-yl-1-[4-(trifluoromethyl)phenyl]-ethanone; 2-Pyrazin-2-yl-1-[4-(trifluoromethyl)phenyl]ethanone; 2-(Pyrazin-2-yl)-1-(4-(trifluoromethyl)phenyl)ethanone; 2-(Pyrazin-2-yl)-[4-(trifluoromethyl)phenyl]ethan-1-one
CAS No.:
88283-34-5
Compound CID:
2782935
Formula:
C13H9F3N2O
Formula Weight:
266.22
Specification
Target:
11β-HSD
Pathway:
Metabolic enzyme/Protease
Storage:
Storage at -20°C.
Applications:
11β-HSD1-IN-9 is widely used to study pathological mechanisms associated with metabolic diseases such as diabetes, obesity and metabolic syndrome.
